The mRNA expression level of YTHDC1, YTHDF1, IGF2BP2, IGF2BP3, HNRNPA2B1, and NKAP were negatively correlated with progression-free survival (PFS) time in HCC patients. This evidence concerns the gene HNRNPA2B1 and hepatocellular carcinoma.